This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stocks to Watch: Midas, Urban Outfitters (update 1)

NEW YORK -- Automotive replacement tires company TBC said it would buy auto services provider Midas (MDS) for $11.50 a share, or about $310 million in cash.

The deal includes the assumption of about $137 million in debt and pension liabilities.

The offer price represents a 75% premium over Midas' closing price of $6.58 on Aug. 11, 2011, when Midas announced it would conduct a strategic review, and a 28% premium over the closing share price on Monday.

Midas shares were surging 27.3% to $11.44 in premarket trading Tuesday.


Urban Outfitters (URBN - Get Report) reported a 9% rise in fourth-quarter net sales to $731 million.

Earnings for the quarter were $39.3 million, or 27 cents a share.

Analysts polled by Thomson Reuters, on average, were expecting EPS of 29 cents on revenue of $741.35 million.

Shares were off 6% to $27.75.


Pharmacy benefits managers Express Scripts (ESRX - Get Report) and Medco Health (MHS) will hold off on completing their $29 billion deal, providing antitrust regulators with more time to finish evaluating the deal, Medco said in a a Securities and Exchange Commission filing.

Medco shares were rising 1.7% to $69.51; Express Scripts shares were rising 1.6% to $54.28.


Google and Facebook are set to begin trial in New Delhi on Tuesday to face charges they didn't censor objectionable content from their sites, The Wall Street Journal reported.

If convicted, executives from the companies could face jail time and the companies could face fines, lawyers following the case said, the newspaper reported.

Google shares were up 0.5% to $608.


Chipmaker Intel (INTC - Get Report) is looking into creating an online pay TV service that can be accessed from TV sets, computers and mobile devices, as it looks to get in on the competitive pay-TV business.

Intel shares were up 0.5% to $27.13.


Johnson & Johnson (JNJ) is facing a U.S. government demand to hike its offer by $800 million from an initial proposal to settle a federal civil investigation into marketing of the antipsychotic Risperdal, Bloomberg reported.

The stock was up 0.2% to $65.25.


Yahoo! (YHOO) filed a lawsuit against its partner Facebook, accusing the social networking giant of patent infringement.

The lawsuit, filed in federal court in San Jose, details patents related to messaging, social networking, privacy, customization and advertising.

"Yahoo! has invested substantial resources in research and development through the years, which has resulted in numerous patented inventions of technology that other companies have licensed," said a Yahoo!spokesman. "Unfortunately, the matter with Facebook remains unresolved and we are compelled to seek redress in federal court -- we are confident that we will prevail."

Facebook expressed surprise at Yahoo!'s legal action.

"We're disappointed that Yahoo's effort to engage with us was limited to a few short phone calls and that we continue to learn of new developments about a long-time partner through the press," a spokesman said in an email. "We will defend ourselves vigorously against these puzzling actions."


FactSet Research (FDS) is expected by analysts to post fiscal second-quarter earnings of $1 a share on revenue of $198.2 million.


Pacific Sunwear (PSUN) will post a fourth-quarter loss Tuesday of 22 cents a share on sales of $245.4 million, according to analysts.


Drug giant AstraZeneca (AZN) is suing the U.S. Food and Drug Administration to extend some of its exclusive rights on the top-selling anti-psychotic drug Seroquel.

-- Written by Joseph Woelfel and Andrea Tse



>To contact the writer of this article, click here: Joseph Woelfel

Related links:
Pandora CEO Talks Sirius XM Challenge, Mobile


Bank of America: When Will It Raise the Dividend?

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
MHS $70.30 0.00%
ESRX $90.44 0.27%
INTC $33.45 -0.30%
URBN $34.84 0.90%
AAPL $132.54 0.88%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs